0001127602-12-027786.txt : 20121002
0001127602-12-027786.hdr.sgml : 20121002
20121002152506
ACCESSION NUMBER: 0001127602-12-027786
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20120928
FILED AS OF DATE: 20121002
DATE AS OF CHANGE: 20121002
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Massingale H. Lynn
CENTRAL INDEX KEY: 0001478236
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34583
FILM NUMBER: 121123147
MAIL ADDRESS:
STREET 1: TEAM HEALTH HOLDINGS
STREET 2: 1900 WINSTON ROAD, SUITE 300
CITY: KNOXVILLE
STATE: TN
ZIP: 37919
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TEAM HEALTH HOLDINGS INC.
CENTRAL INDEX KEY: 0001082754
STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HELP SUPPLY SERVICES [7363]
IRS NUMBER: 364276525
STATE OF INCORPORATION: DE
BUSINESS ADDRESS:
STREET 1: 265 BROOKVIEW CENTRE WAY
STREET 2: SUITE 400
CITY: KNOXVILLE
STATE: TN
ZIP: 37919
BUSINESS PHONE: 865-693-1000
MAIL ADDRESS:
STREET 1: 265 BROOKVIEW CENTRE WAY
STREET 2: SUITE 400
CITY: KNOXVILLE
STATE: TN
ZIP: 37919
FORMER COMPANY:
FORMER CONFORMED NAME: TEAM HEALTH HOLDINGS LLC
DATE OF NAME CHANGE: 19990325
4
1
form4.xml
PRIMARY DOCUMENT
X0306
4
2012-09-28
0001082754
TEAM HEALTH HOLDINGS INC.
TMH
0001478236
Massingale H. Lynn
265 BROOKVIEW CENTRE WAY
SUITE 400
KNOXVILLE
TN
37919
1
1
Executive Chairman
Common Stock
39663
I
See Footnote
Stock Options (Right to Buy)
12.00
2012-09-28
2012-09-28
4
D
0
67973
26.9518
D
2019-12-15
Common Stock
67973
67073
D
Stock Options (Right to Buy)
12.00
2012-10-01
2012-10-01
4
D
0
67073
27.1194
D
2019-12-15
Common Stock
67073
0
D
Stock Options (Right to Buy)
13.40
2012-10-01
2012-10-01
4
D
0
14954
27.1194
D
2020-05-27
Common Stock
14954
15046
D
Stock Options (Right to Buy)
14.93
2019-12-15
Common Stock
303845
303845
D
Stock Options (Right to Buy)
21.64
2021-05-26
Common Stock
30000
30000
D
Stock Options (Right to Buy)
22.09
2022-05-18
Common Stock
50000
50000
D
These shares are held by The H. Lynn Massingale Trust, of which the Reporting Person is the trustee and sole vested beneficiary.
These stock options were excerised and the option shares were sold pursuant to a 10b5-1 plan effective August 20, 2012 between Dr. Massingale and UBS Financial Services, Inc.
The stock options are fully vested and excercisable.
The stock options are fully vested and exercisable with respect to 50% of the underlying shares and the options shall vest 25% on each of the 3rd and 4th anniversary dates of the date of grant.
The stock options are fully vested and excercisable.
The stock options are fully vested and exercisable with respect to 25% of the underlying shares and shall vest and become exercisable with respect to 25% of the remaining underlying shares on each of the 2nd, 3rd and 4th anniversaries of the May 26, 2011 grant date.
The stock options shall vest and become exercisable with respect to 25% of the shares initially covered by the stock options on each of the first, second, third and fourth anniversaries of the May 18, 2012 grant date.
/s/ John R. Stair, attorney-in-fact for Dr. Massingale
2012-10-01